ciprofloxacin has been researched along with Hemolysis in 37 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Hemolysis: The destruction of ERYTHROCYTES by many different causal agents such as antibodies, bacteria, chemicals, temperature, and changes in tonicity.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ciprofloxacin has been associated with several side effects including interstitial nephritis and hemolytic anemia." | 7.72 | Ciprofloxacin-induced acute interstitial nephritis and autoimmune hemolytic anemia. ( Alam, MG; Lim, S, 2003) |
| "Our study indicated the inhibitory effect of ciprofloxacin and ceftriaxone on the level of hemolysis, suggesting that the sub-inhibitory concentrations of these antibiotics may affect the outcome of infections." | 4.12 | Characterization of Escherichia coli isolated from urinary tract infection and association between virulence expression and antimicrobial susceptibility. ( Aghaei, A; Ahmadi, E; Ahmadi, S; Derakhshan, S; Nasseri, S, 2022) |
| "Ciprofloxacin has been associated with several side effects including interstitial nephritis and hemolytic anemia." | 3.72 | Ciprofloxacin-induced acute interstitial nephritis and autoimmune hemolytic anemia. ( Alam, MG; Lim, S, 2003) |
| " Moreover, the cytotoxicity results against L929 fibroblast cell line revealed that p(ML) based particle are biocompatible up to 100 μg/mL with 85% cell viability regardless of their nature, and at 200 μg/mL dosage of p(ML), m-p(ML)/TA and m-p(ML)/DETA particles, the cell viabilities were determined as 83." | 1.48 | One step preparation of polymeric maltitol particles, from a sugar molecule, maltitol for biomedical applications. ( Sahiner, N, 2018) |
| "PVP-CD was proved safe and demonstrated excellent biocompatibility, healing and degradation properties." | 1.38 | Safety, healing, and efficacy of vascular prostheses coated with hydroxypropyl-β-cyclodextrin polymer: experimental in vitro and animal studies. ( Blanchemain, N; Haulon, S; Hildebrand, HF; Jean-Baptiste, E; Martel, B; Neut, C, 2012) |
| "Ophthalmic delivery systems such as ocular inserts are useful strategies to improve the ocular bioavailability of topically administered drugs." | 1.36 | Biodegradable hybrid polymeric membranes for ocular drug delivery. ( Banerjee, R; Carvalho, E; Jain, D, 2010) |
| "Ciprofloxacin resistance was identified in 18% and 6% of consecutively collected, clinically significant urinary tract isolates of Escherichia coli from inpatients and outpatients, respectively." | 1.33 | Decreased prevalence of virulence factors among ciprofloxacin-resistant uropathogenic Escherichia coli isolates. ( Drews, SJ; Green, K; Low, DE; Mazzulli, T; McGeer, AJ; Pong-Porter, S; Poutanen, SM; Rzayev, Y; Sarabia, A; Willey, B, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (13.51) | 18.2507 |
| 2000's | 5 (13.51) | 29.6817 |
| 2010's | 22 (59.46) | 24.3611 |
| 2020's | 5 (13.51) | 2.80 |
| Authors | Studies |
|---|---|
| Nielsen, SF | 1 |
| Larsen, M | 1 |
| Boesen, T | 1 |
| Schønning, K | 1 |
| Kromann, H | 1 |
| Zaknoon, F | 1 |
| Sarig, H | 1 |
| Rotem, S | 1 |
| Livne, L | 1 |
| Ivankin, A | 1 |
| Gidalevitz, D | 1 |
| Mor, A | 1 |
| Abdel-Wahab, BF | 1 |
| Awad, GE | 1 |
| Badria, FA | 1 |
| Singh, MK | 1 |
| Tilak, R | 2 |
| Nath, G | 2 |
| Awasthi, SK | 2 |
| Agarwal, A | 2 |
| Lohan, S | 2 |
| Cameotra, SS | 1 |
| Bisht, GS | 1 |
| Fardeau, S | 1 |
| Dassonville-Klimpt, A | 1 |
| Audic, N | 1 |
| Sasaki, A | 1 |
| Pillon, M | 1 |
| Baudrin, E | 1 |
| Mullié, C | 1 |
| Sonnet, P | 1 |
| Chugunova, E | 1 |
| Akylbekov, N | 1 |
| Bulatova, A | 1 |
| Gavrilov, N | 1 |
| Voloshina, A | 1 |
| Kulik, N | 1 |
| Zobov, V | 1 |
| Dobrynin, A | 1 |
| Syakaev, V | 1 |
| Burilov, A | 1 |
| Kant, R | 1 |
| Singh, V | 1 |
| Dou, X | 2 |
| Zhu, X | 1 |
| Wang, J | 2 |
| Dong, N | 1 |
| Shan, A | 3 |
| Lyu, Y | 1 |
| Yang, X | 2 |
| Goswami, S | 1 |
| Gorityala, BK | 1 |
| Idowu, T | 1 |
| Domalaon, R | 1 |
| Zhanel, GG | 1 |
| Schweizer, F | 1 |
| Sharma, KK | 1 |
| Maurya, IK | 1 |
| Khan, SI | 1 |
| Jacob, MR | 1 |
| Kumar, V | 1 |
| Tikoo, K | 1 |
| Jain, R | 1 |
| Chou, S | 1 |
| Yang, Z | 1 |
| Yang, Y | 1 |
| Wang, Z | 1 |
| Song, J | 1 |
| Dias, FRF | 1 |
| Novais, JS | 1 |
| Devillart, TADNS | 1 |
| da Silva, WA | 1 |
| Ferreira, MO | 1 |
| Loureiro, RS | 1 |
| Campos, VR | 1 |
| Ferreira, VF | 1 |
| de Souza, MCBV | 1 |
| Castro, HC | 1 |
| Cunha, AC | 1 |
| Qiu, Y | 1 |
| Chan, ST | 1 |
| Lin, L | 1 |
| Shek, TL | 1 |
| Tsang, TF | 1 |
| Barua, N | 1 |
| Zhang, Y | 1 |
| Ip, M | 1 |
| Chan, PK | 1 |
| Blanchard, N | 1 |
| Hanquet, G | 1 |
| Zuo, Z | 1 |
| Ma, C | 1 |
| Zhang, PL | 1 |
| Gopala, L | 1 |
| Zhang, SL | 1 |
| Cai, GX | 1 |
| Zhou, CH | 1 |
| Mandal, D | 1 |
| Choi, W | 1 |
| Konshina, AG | 1 |
| Tiwari, RK | 1 |
| Efremov, RG | 1 |
| Maslennikov, I | 1 |
| Parang, K | 1 |
| Langer, MK | 1 |
| Rahman, A | 1 |
| Dey, H | 1 |
| Anderssen, T | 1 |
| Zilioli, F | 1 |
| Haug, T | 1 |
| Blencke, HM | 1 |
| Stensvåg, K | 1 |
| Strøm, MB | 1 |
| Bayer, A | 1 |
| Derakhshan, S | 1 |
| Ahmadi, S | 1 |
| Ahmadi, E | 1 |
| Nasseri, S | 1 |
| Aghaei, A | 1 |
| Aziz-Ur-Rehman, - | 1 |
| Khan, SG | 1 |
| Bokhari, TH | 1 |
| Anjum, F | 1 |
| Akhter, N | 1 |
| Rasool, S | 1 |
| Ali Shah, SA | 1 |
| Shahid, M | 2 |
| Arshad, A | 1 |
| Sahiner, N | 1 |
| Abbasi, MA | 1 |
| Nazeer, MM | 1 |
| Rehman, A | 1 |
| Siddiqui, SZ | 1 |
| Hussain, G | 1 |
| Shah, SA | 1 |
| Ahmad, I | 1 |
| Sarwar, MS | 1 |
| Patel, KK | 1 |
| Tripathi, M | 1 |
| Pandey, N | 1 |
| Agrawal, AK | 1 |
| Gade, S | 1 |
| Anjum, MM | 1 |
| Singh, S | 1 |
| Singh, M | 1 |
| Gadepalli, R | 1 |
| Dhawan, B | 1 |
| Mukhopadhyay, K | 1 |
| Skwor, T | 1 |
| Shinko, J | 1 |
| Augustyniak, A | 1 |
| Gee, C | 1 |
| Andraso, G | 1 |
| Šišková, P | 1 |
| Černohorská, L | 1 |
| Mahelová, M | 1 |
| Turková, K | 1 |
| Woznicová, V | 1 |
| Singh, B | 1 |
| Varshney, L | 1 |
| Sharma, V | 1 |
| Jain, D | 1 |
| Carvalho, E | 1 |
| Banerjee, R | 1 |
| Jean-Baptiste, E | 1 |
| Blanchemain, N | 1 |
| Martel, B | 1 |
| Neut, C | 1 |
| Hildebrand, HF | 1 |
| Haulon, S | 1 |
| Seas, C | 1 |
| Villaverde, H | 1 |
| Maguiña, C | 1 |
| Lim, S | 1 |
| Alam, MG | 1 |
| Drews, SJ | 1 |
| Poutanen, SM | 1 |
| Mazzulli, T | 1 |
| McGeer, AJ | 1 |
| Sarabia, A | 1 |
| Pong-Porter, S | 1 |
| Rzayev, Y | 1 |
| Willey, B | 1 |
| Green, K | 1 |
| Low, DE | 1 |
| Soto, SM | 1 |
| Jimenez de Anta, MT | 1 |
| Vila, J | 1 |
| Flynn, MJ | 1 |
| Slots, J | 1 |
| Andrews, PA | 1 |
| Robinson, GT | 1 |
| Martínez-Martínez, L | 1 |
| Fernández, F | 1 |
| Perea, EJ | 1 |
| Robertson, DG | 1 |
| Epling, GA | 1 |
| Kiely, JS | 1 |
| Bailey, DL | 1 |
| Song, B | 1 |
| Ferguson, J | 1 |
| Johnson, BE | 1 |
37 other studies available for ciprofloxacin and Hemolysis
| Article | Year |
|---|---|
Cationic chalcone antibiotics. Design, synthesis, and mechanism of action.
Topics: Anti-Bacterial Agents; Cations; Chalcones; Colony Count, Microbial; Drug Design; Hemolysis; Humans; | 2005 |
Antibacterial properties and mode of action of a short acyl-lysyl oligomer.
Topics: Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Cell Membrane; Erythrocytes; Escherichia col | 2009 |
Synthesis, antimicrobial, antioxidant, anti-hemolytic and cytotoxic evaluation of new imidazole-based heterocycles.
Topics: Animals; Anti-Bacterial Agents; Antineoplastic Agents; Antioxidants; Bacteria; Cell Proliferation; D | 2011 |
Design, synthesis and antimicrobial activity of novel benzothiazole analogs.
Topics: Anti-Bacterial Agents; Antifungal Agents; Benzothiazoles; Click Chemistry; Drug Design; Fungi; Gram- | 2013 |
Antibacterial evaluation of structurally amphipathic, membrane active small cationic peptidomimetics: synthesized by incorporating 3-amino benzoic acid as peptidomimetic element.
Topics: Anti-Bacterial Agents; Benzoic Acid; Cell Line; Cell Membrane; Drug Design; Drug Resistance, Bacteri | 2014 |
Synthesis and antibacterial activity of catecholate-ciprofloxacin conjugates.
Topics: Anti-Bacterial Agents; Catechols; Ciprofloxacin; Erythrocytes; Hemolysis; Humans; Iron Chelating Age | 2014 |
Synthesis and biological evaluation of novel structural hybrids of benzofuroxan derivatives and fluoroquinolones.
Topics: Anti-Bacterial Agents; Bacteria; Benzoxazoles; Chemistry Techniques, Synthetic; Drug Design; Fluoroq | 2016 |
Design, synthesis and biological evaluation of ciprofloxacin tethered bis-1,2,3-triazole conjugates as potent antibacterial agents.
Topics: Anti-Bacterial Agents; Chemistry Techniques, Synthetic; Ciprofloxacin; Drug Design; Gram-Negative Ba | 2016 |
Novel Design of Heptad Amphiphiles To Enhance Cell Selectivity, Salt Resistance, Antibiofilm Properties and Their Membrane-Disruptive Mechanism.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Biofilms; Circular Dichr | 2017 |
Amphiphilic Tobramycin-Lysine Conjugates Sensitize Multidrug Resistant Gram-Negative Bacteria to Rifampicin and Minocycline.
Topics: Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Positive B | 2017 |
Discovery of a Membrane-Active, Ring-Modified Histidine Containing Ultrashort Amphiphilic Peptide That Exhibits Potent Inhibition of Cryptococcus neoformans.
Topics: Amphotericin B; Animals; Antifungal Agents; Biphenyl Compounds; Cell Line, Tumor; Cell Membrane; Chl | 2017 |
Combating Drug-Resistant Fungi with Novel Imperfectly Amphipathic Palindromic Peptides.
Topics: Amino Acid Sequence; Animals; Antifungal Agents; Candida albicans; Cytoplasm; Drug Resistance, Funga | 2018 |
Synthesis and antimicrobial evaluation of amino sugar-based naphthoquinones and isoquinoline-5,8-diones and their halogenated compounds.
Topics: Amino Sugars; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Halogenation; Hemolysis; Humans | 2018 |
Design, synthesis and biological evaluation of antimicrobial diarylimine and -amine compounds targeting the interaction between the bacterial NusB and NusE proteins.
Topics: Aniline Compounds; Anti-Bacterial Agents; Bacterial Proteins; Benzylamines; Caco-2 Cells; Drug Desig | 2019 |
An unanticipated discovery towards novel naphthalimide corbelled aminothiazoximes as potential anti-MRSA agents and allosteric modulators for PBP2a.
Topics: Allosteric Regulation; Allosteric Site; Anti-Bacterial Agents; Bacterial Proteins; Binding Sites; Dr | 2022 |
Small Amphiphilic Peptides: Activity Against a Broad Range of Drug-Resistant Bacteria and Structural Insight into Membranolytic Properties.
Topics: Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Bacteria; Cell Membrane; Cell Survival; Drug | 2022 |
A concise SAR-analysis of antimicrobial cationic amphipathic barbiturates for an improved activity-toxicity profile.
Topics: Amines; Anti-Bacterial Agents; Anti-Infective Agents; Barbiturates; Cations; Gram-Negative Bacteria; | 2022 |
Characterization of Escherichia coli isolated from urinary tract infection and association between virulence expression and antimicrobial susceptibility.
Topics: Animals; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Escherichia coli; Escherichia coli Infec | 2022 |
Synthesis, characterization, antibacterial, hemolytic and thrombolytic activity evaluation of 5-(3-chlorophenyl)-2-((N-(substituted)-2-acetamoyl)sulfanyl)-1,3,4-oxadiazole derivatives.
Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Fibrinolytic Agents; Hemolysis; Microbial Sensitivit | 2020 |
One step preparation of polymeric maltitol particles, from a sugar molecule, maltitol for biomedical applications.
Topics: Animals; Biocompatible Materials; Blood Coagulation; Cell Line; Cell Survival; Chromosomes; Ciproflo | 2018 |
Synthesis of 2-Furyl[(4-aralkyl)-1-piperazinyl]methanone derivatives as suitable antibacterial agents with mild cytotoxicity.
Topics: Animals; Anti-Bacterial Agents; Carbon-13 Magnetic Resonance Spectroscopy; Cattle; Ciprofloxacin; Gr | 2018 |
Alginate lyase immobilized chitosan nanoparticles of ciprofloxacin for the improved antimicrobial activity against the biofilm associated mucoid P. aeruginosa infection in cystic fibrosis.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Chitosan; Ciprofloxacin; Cystic Fibrosis; Drug Liberation; | 2019 |
Combination of alpha-melanocyte stimulating hormone with conventional antibiotics against methicillin resistant Staphylococcus aureus.
Topics: 3T3 Cells; alpha-MSH; Animals; Anti-Bacterial Agents; Bacterial Proteins; Cell Survival; Ciprofloxac | 2013 |
Aeromonas hydrophila and Aeromonas veronii predominate among potentially pathogenic ciprofloxacin- and tetracycline-resistant aeromonas isolates from Lake Erie.
Topics: Aeromonas; Anti-Bacterial Agents; Cell Survival; Ciprofloxacin; DNA Gyrase; Drug Resistance, Bacteri | 2014 |
Phenotypes of Escherichia coli isolated from urine: Differences between extended-spectrum β-lactamase producers and sensitive strains.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Typing Techniques; beta | 2015 |
Design of sterile mucoadhesive hydrogels for use in drug delivery: effect of radiation on network structure.
Topics: Adhesives; Animals; Ciprofloxacin; Differential Thermal Analysis; Diffusion; Drug Delivery Systems; | 2014 |
Biodegradable hybrid polymeric membranes for ocular drug delivery.
Topics: Animals; Anti-Bacterial Agents; Biocompatible Materials; Carboxymethylcellulose Sodium; Cell Line; C | 2010 |
Safety, healing, and efficacy of vascular prostheses coated with hydroxypropyl-β-cyclodextrin polymer: experimental in vitro and animal studies.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Animals; Anti-Bacterial Agents; beta-Cyclodextrins; Blood Vessel | 2012 |
A 60-year-old man from the highlands of Peru with fever and hemolysis.
Topics: Anemia; Bartonella bacilliformis; Bartonella Infections; Ceftriaxone; Ciprofloxacin; Fever; Hemolysi | 2012 |
Ciprofloxacin-induced acute interstitial nephritis and autoimmune hemolytic anemia.
Topics: Acute Disease; Aged; Anemia, Hemolytic, Autoimmune; Anti-Infective Agents; Ciprofloxacin; Glucosepho | 2003 |
Decreased prevalence of virulence factors among ciprofloxacin-resistant uropathogenic Escherichia coli isolates.
Topics: Bacteriuria; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli; Hemolysis; Humans; Nalidix | 2005 |
Quinolones induce partial or total loss of pathogenicity islands in uropathogenic Escherichia coli by SOS-dependent or -independent pathways, respectively.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field | 2006 |
Beta-hemolytic streptococci in advanced periodontitis.
Topics: Adolescent; Adult; Age Factors; Aged; Ciprofloxacin; Colony Count, Microbial; Cross-Sectional Studie | 1993 |
Intravascular haemolysis and interstitial nephritis in association with ciprofloxacin.
Topics: Anemia, Hemolytic; Anti-Infective Agents; Ciprofloxacin; Female; Hemolysis; Humans; Middle Aged; Nep | 1999 |
Relationship between haemolysis production and resistance to fluoroquinolones among clinical isolates of Escherichia coli.
Topics: Amoxicillin; Ampicillin; Animals; Anti-Infective Agents; Ciprofloxacin; Clavulanic Acid; Drug Resist | 1999 |
Mechanistic studies of the phototoxic potential of PD 117596, a quinolone antibacterial compound.
Topics: 4-Quinolones; Animals; Anti-Infective Agents; Antioxidants; Ciprofloxacin; Dose-Response Relationshi | 1991 |
Ciprofloxacin-induced photosensitivity: in vitro and in vivo studies.
Topics: Adult; Aged; Aged, 80 and over; Animals; Candida albicans; Cells, Cultured; Ciprofloxacin; DNA; Fema | 1990 |